Starna Therapeutics
PrivateLast Round
Series B
Extension
May 11, 2026
Total Funding Raised
$108M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Starna Therapeutics is a biotechnology company that develops innovative RNA-based drugs and vaccines using its proprietary extrahepatic targeted delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Starna Therapeutics Comparables
Compare Starna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOTE Therapeutics | 83% | |
| RongCan Biotech | 82% | |
| Innorna | 82% | |
Starna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 11, 2026 | ||||
| Series B | Oct 22, 2025 | ||||
| Series A | May 16, 2022 | ||||
| Angel | Dec 1, 2021 |
Starna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Primavera Venture Partners | Series A |
| Hillhouse Investment | Series A, Angel, Series B Extension, Series B |
| LYFE Capital | Series B Extension, Series A, Series B |
| Hony Capital | Series A |
| Source Code Capital | Series A, Series B, Series B Extension |
| Primavera Venture Partners | Series A |
| Lilly Asia Ventures | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
$40M raised with participation from Lilly Asia Ventures and others.
- Oct 22, 2025
$44M round completed.
Starna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Starna Therapeutics's valuation, stock price, and market status.